Johnson & Johnson (JNJ) FY2025 Q1 P&L / Income Statement

Johnson & Johnson (JNJ) FY2025 Q1 P&L / Income Statement

Income statement for 2024-12-30 through 2025-03-30. View: Segments by Subsegments. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Sales to customers (Note 9)

21,893,000,000 US dollars

Cost of products sold

7,357,000,000 US dollars

Gross profit

14,536,000,000 US dollars

Operating expenses (calculated)

8,354,000,000 US dollars

Operating profit (calculated)

6,182,000,000 US dollars

Other income (expense), net (calculated)

7,449,000,000 US dollars

Earnings before provision for taxes on income

13,631,000,000 US dollars

Provision for taxes on income (Note 5)

2,632,000,000 US dollars

Net earnings

10,999,000,000 US dollars

Innovative Medicine - Cardiovascular / Metabolism / Other

1,013,000,000 US dollars

Innovative Medicine - Immunology

3,707,000,000 US dollars

Innovative Medicine - Infectious Diseases

802,000,000 US dollars

Innovative Medicine - Neuroscience

1,647,000,000 US dollars

Innovative Medicine - Oncology

5,678,000,000 US dollars

Innovative Medicine - Pulmonary Hypertension

1,025,000,000 US dollars

MedTech - Abiomed

420,000,000 US dollars

MedTech - Cardiovascular

2,103,000,000 US dollars

MedTech - Electrophysiology

1,323,000,000 US dollars

MedTech - Orthopaedics

2,241,000,000 US dollars

MedTech - Other Cardiovascular

103,000,000 US dollars

MedTech - Shockwave

258,000,000 US dollars

MedTech - Surgery

2,396,000,000 US dollars

MedTech - Vision

1,279,000,000 US dollars

Research and development expense

3,225,000,000 US dollars

Restructuring (Note 12)

17,000,000 US dollars

Selling, marketing and administrative expenses

5,112,000,000 US dollars

Revenue before reconciliation (calculated)

23,995,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Components above reported revenue (calculated)

negative 2,102,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.